Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial

NCT07184307 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder Syndrome
Urinary Urge Incontinence
Detrusor Overactivity

Interventions

BIOLOGICAL: Platelet-Rich Plasma
DRUG: Intravesical Botulinum Toxin Injection

Sponsor

Benha University